TickerFactsScreenerDevelopers

Moleculin Biotech, Inc. (MBRX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2015: $28.0K2016: $5.01M2017: $7.71M2018: $7.13M2019: $10.73M2020: $15.17M2021: $70.90M2022: $43.15M2023: $23.55M2024: $4.28M2025: $8.88M$8.88M
2015Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$8.88M+107.5%
2024$4.28M-81.8%
2023$23.55M-45.4%
2022$43.15M-39.1%
2021$70.90M+367.3%
2020$15.17M+41.3%
2019$10.73M+50.5%
2018$7.13M-7.5%
2017$7.71M+54.1%
2016$5.01M+17782.1%
2015$28.0K—